29 results
S-3ASR
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
reported initial Phase 1b data from this trial at the European Society for Medical Oncology (ESMO) Congress in October 2023, which demonstrated both … myeloma and reported initial Phase 1b data from this trial at the American Society of Hematology (ASH) annual meeting in December 2023. We intend
8-K
EX-99.1
ORIC
ORIC Pharmaceuticals Inc
9 Jan 24
Results of Operations and Financial Condition
9:00am
may represent up to 6.5% of NSCLC (>12,500 patients) in the US annually Source: American Cancer Society Cancer Facts & Figures 2023, Gainor et al
S-3
yprpeg
15 Dec 23
Shelf registration
4:32pm
8-K
EX-99.1
4016y6xf7 3vd3t1stm
11 Dec 23
Other Events
4:05pm
8-K
973 pzw269
11 Dec 23
Other Events
4:05pm
8-K
azq4w8b
23 Oct 23
Other Events
4:07pm
8-K
EX-99.1
eufp0crg
23 Oct 23
Other Events
4:07pm
8-K
EX-99.1
14ghj6
10 Aug 23
ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
4:11pm
8-K
EX-99.1
ci8ndb1jk pmuwjdovm3
7 Nov 22
ORIC Pharmaceuticals Reports Third Quarter 2022
4:10pm
8-K
EX-99.1
lyude tgrx2uj9hl
21 Mar 22
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021
4:07pm
8-K
EX-99.1
9j0d59hee
8 Nov 21
ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update
4:16pm
8-K
EX-99.1
v1e6r 5u3hbxtfsugy3
21 Jun 21
ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel
4:06pm
8-K
EX-99.1
hl967k8ioi 14rzl9j
6 May 21
ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
4:10pm
10-K
uq9fi rk8k
23 Mar 21
Annual report
4:21pm
8-K
EX-99.2
94xri0ew 8gu
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am